Citigroup Inc. lessened its stake in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 26.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 339,295 shares of the company’s stock after selling 124,179 shares during the quarter. Citigroup Inc. owned about 0.21% of Option Care Health worth $9,419,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently modified their holdings of the company. Cornerstone Planning Group LLC grew its stake in shares of Option Care Health by 7,621.4% during the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after purchasing an additional 1,067 shares during the last quarter. McIlrath & Eck LLC bought a new position in Option Care Health in the 2nd quarter valued at $37,000. Hantz Financial Services Inc. boosted its position in Option Care Health by 987.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 1,414 shares of the company’s stock valued at $39,000 after buying an additional 1,284 shares during the last quarter. Elevation Point Wealth Partners LLC acquired a new stake in shares of Option Care Health in the 2nd quarter valued at $40,000. Finally, EverSource Wealth Advisors LLC raised its position in shares of Option Care Health by 528.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after acquiring an additional 1,183 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Option Care Health Price Performance
Shares of OPCH stock opened at $32.46 on Monday. Option Care Health, Inc. has a 12-month low of $24.24 and a 12-month high of $36.80. The firm has a market capitalization of $5.08 billion, a price-to-earnings ratio of 25.36, a price-to-earnings-growth ratio of 1.82 and a beta of 0.85. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 0.87. The firm has a fifty day moving average of $33.99 and a 200-day moving average of $30.60.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on the company. TD Cowen reiterated a “hold” rating on shares of Option Care Health in a report on Tuesday, January 27th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. Morgan Stanley boosted their price target on shares of Option Care Health from $35.00 to $38.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 13th. Barrington Research increased their price objective on shares of Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a report on Friday, January 16th. Finally, Truist Financial set a $40.00 price objective on shares of Option Care Health in a research note on Tuesday, January 13th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Option Care Health presently has a consensus rating of “Moderate Buy” and an average price target of $37.58.
Check Out Our Latest Report on OPCH
Option Care Health Profile
Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.
Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.
Further Reading
- Five stocks we like better than Option Care Health
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- Unlocked: Elon Musk’s Next Big IPO
- Silver paying 20% dividend. Plus 68% share gains
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
